a:head bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

a:head bio General Information

Description

Developer of novel drugs intended for treating brain disorders based on human cerebral organoids. The company develops 3D tissue cultures from human stem cells through in vitro experiments to understand the brain's developmental processes, enabling healthcare professionals to improve the lives of patients suffering from central nervous system diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Drive -Bohr-Gasse 7
  • VBC6
  • Vienna, 1030
  • Austria
+43 01
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Drive -Bohr-Gasse 7
  • VBC6
  • Vienna, 1030
  • Austria
+43 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

a:head bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-Sep-2026 Completed Generating Revenue
6. Later Stage VC 17-Apr-2025 Completed Generating Revenue
5. Later Stage VC 09-Oct-2024 Completed Generating Revenue
4. Early Stage VC (Series A) Cancelled Clinical Trials - General
3. Early Stage VC 22-Feb-2021 Completed Clinical Trials - General
2. Grant 24-Oct-2019 $2.75M $1.68M Completed Clinical Trials - General
1. Seed Round 07-Aug-2019 $1.68M $1.68M Completed Clinical Trials - General
To view a:head bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

a:head bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

a:head bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hansmann Family Office Venture Capital Minority
The Austrian Research Promotion Agency Government
red-stars.com data Holding Company Minority
To view a:head bio’s complete investors history, request access »

a:head bio FAQs

  • When was a:head bio founded?

    a:head bio was founded in 2019.

  • Where is a:head bio headquartered?

    a:head bio is headquartered in Vienna, Austria.

  • What is the size of a:head bio?

    a:head bio has 19 total employees.

  • What industry is a:head bio in?

    a:head bio’s primary industry is Surgical Devices.

  • Is a:head bio a private or public company?

    a:head bio is a Private company.

  • What is a:head bio’s current revenue?

    The current revenue for a:head bio is .

  • How much funding has a:head bio raised over time?

    a:head bio has raised $1.68M.

  • Who are a:head bio’s investors?

    Hansmann Family Office, The Austrian Research Promotion Agency, and red-stars.com data have invested in a:head bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process